Linde (ETR:LIN) Stock Upgrade
In analysts note disseminated on 8 December, Bernstein Research has hiked shares of Linde (ETR:LIN) stock to a solid Outperform and has established a 12month target price to EUR 167.00. This target is 21.01% from LIN’s current share price.
From a total of 3 analysts covering Linde (ETR:LIN) stock, 0 rate it a ”Buy”, 0 a “Sell”, and 0 a ”Hold”. This means that NaN of the ratings are positive. The highest target price is €28 while the lowest target price is €26. The mean of all analyst targets is €27 with a 31.52% above today’s (€138.1) stock price. Linde was the topic of 49 analyst reports since July 17, 2015 according to the firm StockzIntelligence Inc. JP Morgan maintained shares on December 3 with “Neutral” rating. Kepler Cheuvreux downgraded shares to “Reduce” rating and €170 target share price in a report from a December 2. Warburg Research upgraded LIN stock in a recent report from December 2 to “Buy” rating. Hauck & Aufhäuser Privatbankiers KGaA upgraded the rating on December 2. Hauck & Aufhäuser Privatbankiers KGaA has a “Buy” rating and a €181 price target on shares. Finally, UBS downgraded the stock to “Sell” rating in a report issued on a December 2.
The stock increased 0.29% or EUR 0.4 on December 7, striking EUR 138.1. Approximately 838,283 shares of stock traded hands or 25.37% up from the average. Linde AG (ETR:LIN) has risen 1.50% since May 23, 2014 and is uptrending. It has outperformed by 2.58% the S&P500.
Linde AG is a Germany-based company engaged in the gas and engineering sectors. The company has a market cap of 25.65 billion EUR. It operates three divisions: Gases; Engineering , as well as Gist. It has 22.5 P/E ratio. The Gases Division includes Healthcare, producing medical gases; and Tonnage, as its two global business units; as well as the two business areas Merchant and Packaged Gases, offering liquefied and cylinder gases, and Electronics.